Molecular and Cellular Biochemistry

, Volume 372, Issue 1–2, pp 221–231 | Cite as

PI3 kinase/Akt/HIF-1α pathway is associated with hypoxia-induced epithelial–mesenchymal transition in fibroblast-like synoviocytes of rheumatoid arthritis

  • Guo-Qing Li
  • Yu Zhang
  • Dan Liu
  • Ya-Yun Qian
  • Hua Zhang
  • Shi-Yu Guo
  • Masataka Sunagawa
  • Tadashi Hisamitsu
  • Yan-Qing LiuEmail author


Migration and invasion of fibroblast-like synoviocytes (FLSs) are critical in the pathogenesis of rheumatoid arthritis (RA). Hypoxic conditions are present in RA joints, and hypoxia has been extensively studied in angiogenesis and inflammation. However, its effect on the migration and invasion of RA-FLSs remains unknown. In this study, we observed that RA-FLSs exposed to hypoxic conditions experienced epithelial–mesenchymal transition (EMT), with increased cell migration and invasion. We demonstrated that hypoxia-induced EMT was accompanied by increased hypoxia-inducible factor (HIF)-1α expression and activation of Akt. After knockdown or inhibition of HIF-1α in hypoxia by small interfering RNA or genistein (Gen) treatment, the EMT transformation and invasion ability of FLSs were regained. HIF-1α could be blocked by phosphatidylinositol 3-kinase (PI3K) inhibitor, LY294002, indicating that HIF-1α activation was regulated by the PI3K/Akt pathway. Administration of LY294002 (20 mg/kg, intra-peritoneally) twice weekly and Gen (25 mg/kg, by gavage) daily for 3 weeks from day 20 after primary immunization in a collagen-induced arthritis rat model, markedly alleviated the clinical signs, radiology progression, synovial hyperplasia, and inflammatory cells infiltration of joints. Thus, results of this study suggest that activation of the PI3K/Akt/HIF-1α pathway plays a pivotal role in mediating hypoxia-induced EMT transformation and invasion of RA-FLSs under hypoxia.


Hypoxia Epithelial–mesenchymal transition Fibroblast-like synoviocytes HIF-1α PI3K/Akt Rheumatoid arthritis 



This research was sponsored by the Graduate Student Research and Innovation Program of Jiangsu Province (No.CXZZ11-0998).


  1. 1.
    Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423:356–361. doi: 10.1038/nature01661 PubMedCrossRefGoogle Scholar
  2. 2.
    Feldmann M, Brennan FM, Maini RN (1996) Rheumatoid arthritis. Cell 85:307–310. doi: 10.1016/S0092-8674(00)81109-5 PubMedCrossRefGoogle Scholar
  3. 3.
    Klareskog L, Catrina AI, Paget S (2009) Rheumatoid arthritis. Lancet 373:659–672. doi: 10.1016/S0140-6736(09)60008-8 PubMedCrossRefGoogle Scholar
  4. 4.
    van Vollenhoven RF (2009) Treatment of rheumatoid arthritis: state of the art 2009. Nat Rev Rheumatol 5:531–541. doi: 10.1038/nrrheum.2009.182 PubMedCrossRefGoogle Scholar
  5. 5.
    Huber LC, Distler O, Tarner I, Gay RE, Gay S, Pap T (2006) Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford) 45:669–675. doi: 10.1093/rheumatology/kel065 CrossRefGoogle Scholar
  6. 6.
    Baier A, Meineckel I, Gay S, Pap T (2003) Apoptosis in rheumatoid arthritis. Curr Opin Rheumatol 15:274–279. doi: 10.1097/00002281-200305000-00015 PubMedCrossRefGoogle Scholar
  7. 7.
    Karouzakis E, Gay RE, Gay S, Neidhart M (2009) Epigenetic control in rheumatoid arthritis synovial fibroblasts. Nat Rev Rheumatol 5:266–272. doi: 10.1038/nrrheum.2009.55 PubMedCrossRefGoogle Scholar
  8. 8.
    Tolboom TC, van der Helm-Van Mil AH, Nelissen RG, Breedveld FC, Toes RE, Huizinga TW (2005) Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis. Arthritis Rheum 52:1999–2002. doi: 10.1002/art.21118 PubMedCrossRefGoogle Scholar
  9. 9.
    Muller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, Gay S (1996) Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 149:1607–1615PubMedGoogle Scholar
  10. 10.
    Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420–1428. doi: 10.1172/JCI39104 PubMedCrossRefGoogle Scholar
  11. 11.
    Zhang HJ, Wang HY, Zhang HT, Su JM, Zhu J, Wang HB, Zhou WY, Zhang H, Zhao MC, Zhang L, Chen XF (2011) Transforming growth factor-beta1 promotes lung adenocarcinoma invasion and metastasis by epithelial-to-mesenchymal transition. Mol Cell Biochem 355:309–314. doi: 10.1007/s11010-011-0869-3 PubMedCrossRefGoogle Scholar
  12. 12.
    Hitchon CA, El-Gabalawy HS, Bezabeh T (2009) Characterization of synovial tissue from arthritis patients: a proton magnetic resonance spectroscopic investigation. Rheumatol Int 29:1205–1211. doi: 10.1007/s00296-009-0865-z PubMedCrossRefGoogle Scholar
  13. 13.
    Sivakumar B, Akhavani MA, Winlove CP, Taylor PC, Paleolog EM, Kang N (2008) Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis. J Hand Surg Am 33:49–58. doi: 10.1016/j.jhsa.2007.09.002 PubMedCrossRefGoogle Scholar
  14. 14.
    Steenvoorden MM, Tolboom TC, van der Pluijm G, Lowik C, Visser CP, DeGroot J, Gittenberger-DeGroot AC, DeRuiter MC, Wisse BJ, Huizinga TW, Toes RE (2006) Transition of healthy to diseased synovial tissue in rheumatoid arthritis is associated with gain of mesenchymal/fibrotic characteristics. Arthritis Res Ther 8:R165. doi: 10.1186/ar2073 PubMedCrossRefGoogle Scholar
  15. 15.
    Ekwall AK, Eisler T, Anderberg C, Jin C, Karlsson N, Brisslert M, Bokarewa MI (2011) The tumour-associated glycoprotein podoplanin is expressed in fibroblast-like synoviocytes of the hyperplastic synovial lining layer in rheumatoid arthritis. Arthritis Res Ther 13:R40. doi: 10.1186/ar3274 PubMedCrossRefGoogle Scholar
  16. 16.
    Lefevre S, Knedla A, Tennie C, Kampmann A, Wunrau C, Dinser R, Korb A, Schnaker EM, Tarner IH, Robbins PD, Evans CH, Sturz H, Steinmeyer J, Gay S, Scholmerich J, Pap T, Muller-Ladner U, Neumann E (2009) Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 15:1414–1420. doi: 10.1038/nm.2050 PubMedCrossRefGoogle Scholar
  17. 17.
    Westra J, Limburg PC, de Boer P, van Rijswijk MH (2004) Effects of RWJ 67657, a p38 mitogen activated protein kinase (MAPK) inhibitor, on the production of inflammatory mediators by rheumatoid synovial fibroblasts. Ann Rheum Dis 63:1453–1459. doi: 10.1136/ard.2003.013011 PubMedCrossRefGoogle Scholar
  18. 18.
    Tsubaki T, Arita N, Kawakami T, Shiratsuchi T, Yamamoto H, Takubo N, Yamada K, Nakata S, Yamamoto S, Nose M (2005) Characterization of histopathology and gene-expression profiles of synovitis in early rheumatoid arthritis using targeted biopsy specimens. Arthritis Res Ther 7:R825–R836. doi: 10.1186/ar1751 PubMedCrossRefGoogle Scholar
  19. 19.
    Sleeman JP, Thiery JP (2011) SnapShot: the epithelial-mesenchymal transition. Cell 145(162):e1. doi: 10.1016/j.cell.2011.03.029 PubMedGoogle Scholar
  20. 20.
    Liu L, Zhu XD, Wang WQ, Shen Y, Qin Y, Ren ZG, Sun HC, Tang ZY (2010) Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis. Clin Cancer Res 16:2740–2750. doi: 10.1158/1078-0432.CCR-09-2610 PubMedCrossRefGoogle Scholar
  21. 21.
    Lee YA, Kim JY, Hong SJ, Lee SH, Yoo MC, Kim KS, Yang HI (2007) Synovial proliferation differentially affects hypoxia in the joint cavities of rheumatoid arthritis and osteoarthritis patients. Clin Rheumatol 26:2023–2029. doi: 10.1007/s10067-007-0605-2 PubMedCrossRefGoogle Scholar
  22. 22.
    Wang AZ, Wang JC, Fisher GW, Diamond HS (1997) Interleukin-1beta-stimulated invasion of articular cartilage by rheumatoid synovial fibroblasts is inhibited by antibodies to specific integrin receptors and by collagenase inhibitors. Arthritis Rheum 40:1298–1307PubMedGoogle Scholar
  23. 23.
    Konisti S, Kiriakidis S, Paleolog EM (2012) Hypoxia–a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nat Rev Rheumatol 8:153–162. doi: 10.1038/nrrheum.2011.205 PubMedCrossRefGoogle Scholar
  24. 24.
    Gao W, Sweeney C, Connolly M, Kennedy A, Ng CT, McCormick J, Veale DJ, Fearon U (2012) Notch-1 mediates hypoxia-induced angiogenesis in rheumatoid arthritis. Arthritis Rheum 64:2104–2113. doi: 10.1002/art.34397 PubMedCrossRefGoogle Scholar
  25. 25.
    Azab AK, Hu J, Quang P, Azab F, Pitsillides C, Awwad R, Thompson B, Maiso P, Sun JD, Hart CP, Roccaro AM, Sacco A, Ngo HT, Lin CP, Kung AL, Carrasco RD, Vanderkerken K, Ghobrial IM (2012) Hypoxia promotes dissemination of multiple myeloma through acquisition of endothelial to mesenchymal transition-like features. Blood 119:5782–5794. doi: 10.1182/blood-2011-09-380410 PubMedCrossRefGoogle Scholar
  26. 26.
    Cheng ZX, Sun B, Wang SJ, Gao Y, Zhang YM, Zhou HX, Jia G, Wang YW, Kong R, Pan SH, Xue DB, Jiang HC, Bai XW (2011) Nuclear factor-kappaB-dependent epithelial to mesenchymal transition induced by HIF-1alpha activation in pancreatic cancer cells under hypoxic conditions. PLoS ONE 6:e23752. doi: 10.1371/journal.pone.0023752 PubMedCrossRefGoogle Scholar
  27. 27.
    Mattey DL, Dawes PT, Nixon NB, Slater H (1997) Transforming growth factor beta 1 and interleukin 4 induced alpha smooth muscle actin expression and myofibroblast-like differentiation in human synovial fibroblasts in vitro: modulation by basic fibroblast growth factor. Ann Rheum Dis 56:426–431. doi: 10.1136/ard.56.7.426 PubMedCrossRefGoogle Scholar
  28. 28.
    Eyden B (2004) Fibroblast phenotype plasticity: relevance for understanding heterogeneity in “fibroblastic” tumors. Ultrastruct Pathol 28:307–319. doi: 10.1080/019131290882204 PubMedCrossRefGoogle Scholar
  29. 29.
    Kasperkovitz PV, Timmer TC, Smeets TJ, Verbeet NL, Tak PP, van Baarsen LG, Baltus B, Huizinga TW, Pieterman E, Fero M, Firestein GS, van der Pouw Kraan TC, Verweij CL (2005) Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: evidence of a link between an increased myofibroblast-like phenotype and high-inflammation synovitis. Arthritis Rheum 52:430–441. doi: 10.1002/art.20811 PubMedCrossRefGoogle Scholar
  30. 30.
    Hitchon C, Wong K, Ma G, Reed J, Lyttle D, El-Gabalawy H (2002) Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis Rheum 46:2587–2597. doi: 10.1002/art.10520 PubMedCrossRefGoogle Scholar
  31. 31.
    Giatromanolaki A, Sivridis E, Maltezos E, Athanassou N, Papazoglou D, Gatter KC, Harris AL, Koukourakis MI (2003) Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 5:R193–R201. doi: 10.1186/ar756 PubMedCrossRefGoogle Scholar
  32. 32.
    Hot A, Zrioual S, Lenief V, Miossec P (2012) IL-17 and tumour necrosis factor alpha combination induces a HIF-1alpha-dependent invasive phenotype in synoviocytes. Ann Rheum Dis 71:1393–1401. doi: 10.1136/annrheumdis-2011-200867 PubMedCrossRefGoogle Scholar
  33. 33.
    Tafani M, Schito L, Pellegrini L, Villanova L, Marfe G, Anwar T, Rosa R, Indelicato M, Fini M, Pucci B, Russo MA (2011) Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1/2 and Akt and nuclear translocation of NF-{kappa}B. Carcinogenesis 32:1167–1175. doi: 10.1093/carcin/bgr101 PubMedCrossRefGoogle Scholar
  34. 34.
    He Y, Fan J, Lin H, Yang X, Ye Y, Liang L, Zhan Z, Dong X, Sun L, Xu H (2011) The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1alpha in human rheumatoid arthritis fibroblast-like synoviocyte. Rheumatol Int 31:53–60. doi: 10.1007/s00296-009-1218-7 PubMedCrossRefGoogle Scholar
  35. 35.
    Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, Firestein GS, Gerber HP, Ferrara N, Johnson RS (2003) HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112:645–657. doi: 10.1016/S0092-8674(03)00154-5 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Guo-Qing Li
    • 1
  • Yu Zhang
    • 1
  • Dan Liu
    • 1
  • Ya-Yun Qian
    • 2
  • Hua Zhang
    • 2
  • Shi-Yu Guo
    • 3
  • Masataka Sunagawa
    • 3
  • Tadashi Hisamitsu
    • 3
  • Yan-Qing Liu
    • 2
    Email author
  1. 1.Department of Rheumatology, Clinical Medical CollegeYangzhou UniversityYangzhouChina
  2. 2.Institution of Combining Chinese Traditional and Western Medicine, Medical CollegeYangzhou UniversityYangzhouChina
  3. 3.Department of Physiology, School of MedicineShowa UniversityTokyoJapan

Personalised recommendations